Mitondra Therapeutics
PrivateCompany Overview
Mitondra Therapeutics is a biotechnology company that develops first-in-class small-molecule therapies to restore mitochondrial health by stimulating mitophagy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologydrug discoverysmall-molecule therapeuticsmitophagyPINK1 activatorsmitochondrial dysfunctionbiotech startupage-related diseasesdrug licensingtherapeutic pipelinebiopharmapreclinical researchtranslational medicineneurodegenerative research
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mitondra Therapeutics Comparables
Compare Mitondra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MitoRx Therapeutics | 85% | |
| Vincere Biosciences | 83% | |
| Capacity Bio | 83% | |
Mitondra Therapeutics Funding Rounds
Historical fundraising activity
Mitondra Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mitondra Therapeutics's valuation, stock price, and market status.